Oxygenta Pharmaceutical Ltd — Insider Trade, 01-01-1970: Insider Trading / SAST

The company has announced a board meeting to review the financial results for the quarter and half-year. This update signals upcoming disclosures that will provide insight into the company’s recent performance, helping investors assess operational efficiency and profitability trends. No additional operational or strategic changes were highlighted, keeping the focus on the forthcoming financial data relevant for shareholders’ evaluation.